NeoFertility is a restorative reproductive medicine framework developed at a clinic in Dublin, Ireland. It uses cycle charting, hormone testing, and surgery to find and treat the causes of infertility, recurrent miscarriage, and high-risk pregnancy.1 It builds on the diagnostic method of NaProTechnology. It adds immune markers, androgen levels, and a full workup of both partners.
The clinic describes its care in three stages.1 Stage one is diagnosis. Clinicians check cycle patterns, hormone levels, anatomy, and immune markers in both partners. Stage two is treatment. The team treats what it finds. Treatment may include surgery, hormone support, changes in nutrition, or immune care. Stage three covers the timing of conception, confirmation that ovulation occurred, and support through early pregnancy.
NeoFertility accepts charts from any fertility awareness method, not only the Creighton Model. Its own digital charting tool is ChartNeo. Its hormone panel is wider than a standard fertility workup. Low ovarian reserve is one example. In that case, DHEA supplementation may be considered after an individual evaluation. Clinicians review immune causes of failed implantation and recurrent loss within the immune-modifying framework.
Some of this work has been published in peer-reviewed journals. One case report describes a woman with five miscarriages and low androgen levels. She carried a pregnancy after treatment with oral DHEA.2 A case report covers one patient. It shows what is possible, not how often a treatment works.
The framework is restorative in principle. The first question is why a couple has not conceived, or why a pregnancy did not continue. Treatment targets those causes instead of bypassing them. A 2025 study of restorative reproductive medicine outcomes reported live births among couples who had not conceived before treatment.3
Cited in this entry
- NeoFertility. https://neofertility.ie/
- Boyle PC, Pandalache C, Turczynski C. Successful pregnancy using oral DHEA treatment for hypoandrogenemia in a 30-year-old female with 5 recurrent miscarriages, including fetal demise at 24 weeks: a case report. Frontiers in Medicine. 2024;11:1358563. https://pubmed.ncbi.nlm.nih.gov/38426161/
- Boyle P, Toth A, Minjeur M, Turczynski C. Restorative reproductive medicine (RRM) outcomes compared to in-vitro fertilization (IVF) for the treatment of infertility: a retrospective evaluation of a 2019 clinic cohort. https://rrmacademy.org/library/restorative-reproductive-medicine-rrm-outcomes-compared-to-in-vitro-fertilization-rec4qqhafqb8stlnd/
This content is for educational purposes only and does not constitute medical advice. Consult an RRM clinician or healthcare provider for guidance specific to your situation.
